Pfizer Expected To Seek Authorization For COVID-19 Vaccine Booster For People 18 And Older
Pfizer is expected to seek FDA emergency use authorization for a Covid-19 vaccine booster shot for people 18 and older, making them available to all adults.
Watch CBS News
Pfizer is expected to seek FDA emergency use authorization for a Covid-19 vaccine booster shot for people 18 and older, making them available to all adults.
Pfizer said Friday its experimental pill designed to fight coronavirus reduced the risk of hospitalization and death for high-risk patients.
Governor Charlie Baker said there are now more than 500 locations in Massachusetts that will have Pfizer's COVID-19 pediatric vaccines, now that children ages 5-to-11 are eligible for it.
A lot of parents are anxious to get their school-aged children vaccinated against COVID, but there are a lot of parents out there who may not be convinced yet.
CVS and Walgreens will start providing Pfizer's coronavirus vaccine for children ages 5-to-11 starting this weekend.
Pfizer says its' shot for 5-to-11 year-olds is more than 90-percent effective.
The Food and Drug Administration has paved the way for children ages 5 to 11 to get Pfizer's COVID-19 vaccine.
The first COVID-19 vaccine for children under 12 earned the backing of a Food and Drug Administration advisory panel on Tuesday.
Pfizer says its vaccine is safe and 90.7% effective against symptomatic COVID-19 in children ages 5 to 11.
These are the first results from a randomized, controlled Covid-19 vaccine booster trial.
An independent expert panel will publicly debate the evidence on Oct. 26.
This is the first submission of data to the FDA for a Covid-19 vaccine for younger children.
CVS and Walgreens say they will have the Pfizer COVID-19 vaccine booster shots for those who are eligible.
There is no formal official list of who can and who can't get a booster, but the Centers for Disease Control and Prevention updated its guidance Friday on eligibility.
Dr. Mallika Marshall answers questions about the FDA's decision to authorize booster doses of the Pfizer vaccine for senior citizens and other high-risk groups.
Pfizer had argued that it had enough evidence that immunity starts to wane after six months and that giving a booster restores the immunity safely.
An influential federal advisory panel on Friday unanimously endorsed Pfizer's booster shots against COVID-19 only to Americans 65 and over or at high risk for severe disease.
The move could boost vaccination efforts in the United States.
Full US Food and Drug Administration approval of the Pfizer/BioNTech Covid-19 vaccine is "imminent," a senior federal official told CNN on Friday.
Pfizer has reversed course after saying it would no longer make sight saving eye drops that hundreds of children desperately need.
New data from Pfizer claims a third dose of its' COVID-19 vaccine can "strongly" boost protection against the Delta variant, beyond the protection from the standard two doses.
Many parents are eager to vaccinate younger children as schools prepare to open for in-person learning in the fall.
Pfizer is asking the FDA for emergency use authorization for a third dose of its COVID-19 vaccine.
CDC researchers found a "likely association" between the shots and rare cases of heart inflammation in young people.
A fire at a Pfizer facility in Massachusetts that makes the coronavirus vaccine did not disrupt production, the company said.
